The March 13, 2019 (Vol. 6, No. 4) issue of MedTech Strategist, the main specialist journal covering the global medical device industry, devoted an article on Salvia BioElectronics: “Salvia BioElectronics: a neurostimulation platform for migraine.” The MedTech Strategist listed Salvia as ‘startup-to-watch’ in this 2-page interview with Salvia’s CEO Hubert Martens, who explains the indication that Salvia addresses and the company’s ambition to provide an effective drug-free solution for chronic migraine that is as easy as taking meds.

The original article can be found here.